Clarifying the JZ and JW Modifiers for Success: A Key Question to Crack Comprehension

Clarifying the JZ and JW Modifiers for Success: A Key Question to Crack Comprehension

Understanding how to accurately code and bill for medications and radiopharmaceuticals can be a complex process, especially with ongoing changes in Medicare policies. The JZ modifier, in particular, may prove difficult to comprehend as this modifier is one of the newest modifiers approved. This article explores a relevant question answered by our experts that examines the guidelines set by Medicare for coding and billing these scenarios, particularly focusing on the use of the JW and JZ modifiers for documenting discarded drugs. We’ll break down various examples to help clarify these billing practices and ensure compliance with the latest Medicare regulations.

QUESTION: How do we code and bill for adenosine when we do not use the entire vial on a Medicare patient? Also does this policy apply to radiopharmaceuticals or for all single use administered drugs and diagnostic or therapeutic radiopharmaceuticals?

ANSWER:

Medicare only covers discarded drugs for single use vials; multi-use vials are not subject to payment for discarded amounts of drugs. Since adenosine is supplied as a single use vial, there are several scenarios regarding how to code and bill based on the vial used, (60 mg or 90 mg) and the patient administered dose, which is based on the patients’ weight.

Medicare encourages physicians to schedule patients in such a way that they can use drugs or radiopharmaceuticals most efficiently. However, if a physician must discard the remainder of a single use vial, the Medicare program covers the amount of drug or radiopharmaceutical discarded/decayed/wasted along with the amount administered.

Effective July 1, 2023, providers of separately paid drugs or radiopharmaceuticals from single use administrations are now required to report the waste with the JW modifier or if there is no waste to report the JZ modifier. This is important for CMS tracking and for consistency across the Medicare Administrative Contractors (MACs).

Note: There have been many changes to coding for adenosine from 2013 to 2015 for dates of service prior to January 1, 2014, providers use HCPCS level

II code J0152, Injection, Adenosine, for diagnostic use, per 30 mg increments, for dates of service January 1, 2014 to December 31, 2014 providers would report the new in 2014 HCPCS level II code J0151 Injection, Adenosine, for diagnostic use, per milligram and for dates of service on or after January 1, 2015 and beyond use HPCPS level II code J0153 Injection, Adenosine, diagnostic, per milligram

  • DOS on or after January 1, 2015, and Example 3 added for claims
  • DOS on or after July 1, 2023

Example 1: Patient receives 45 milligrams of adenosine from a 60-milligram vial. The HCPCS Level II code description is J0153 Injection, adenosine, per mg, therefore code and bill for (45) units of J0153 on one line and drop down to a second line to bill the wasted 15 units of J0153 with the JW modifier.

If the non-Medicare payer does not require the JW modifier it would also be correct to bill 60 mg of J0153. Since the description is per 1-milligram increments, it is appropriate to account for this waste by simply rounding up to the nearest whole vial. The same would hold true if the patient received 64 milligrams that was taken from a 90-milligram vial, the provider would code and bill for (90) units of J0153 or split 64 units on line one with 26 units and document that the rest of the vial was discarded. We expect that providers plan accordingly and not waste 90 milligram vials excessively.

Example 2: Patient receives 45 milligrams of adenosine from a 90-milligram vial. In this instance the provider did not have any 60-milligram vials on hand as the patient was an add-on for that day, or the site did not have a correct weight for the patient upon scheduling. For any Medicare contractor the wasted drugs must be billed on a separate line using the HCPCS modifier JW, description Drug Amount Discarded/Not Administered to Any Patient, the provider would bill for (45) units of J0153 and (45) units of J0153-JW

Example 3: Patient receives 60 milligrams of adenosine from a 60-milligram vial. The HCPCS Level II code description is J0153 Injection, adenosine, per mg, therefore code and bill for (60) units of J0153 with the required by Medicare JZ modifier.

If billing a non-Medicare private payer that does not require the JW or JZ modifier, follow the private payer instructions.

Of note, effective for claims with DOS on or after January 1, 2017, Medicare requires the use of the JW modifier for wasted drugs or radiopharmaceuticals.

Additionally, effective for claims with DOS on or after July 1, 2023, Medicare requires the use of JW and JZ for single use drugs or radiopharmaceuticals for tracking and payment. For more information and CMS Q&A on the JW and JZ modifiers go to https://www.cms.gov/medicare/medicare-fee-forservice- payment/hospitaloutpatientpps/downloads/jw-modifier-faqs.pdf. This excerpt is sourced from our 2024 Nuclear Medicine & PET Coder. Remember to take advantage of our expertly aggregated resources to overcome complex challenges in this area and others.

Note that: The opinions referenced are those of the members of the SNMMI Coding and Reimbursement Committee and their consultants based on their coding experience. They are based on the commonly used codes in Nuclear Medicine, which are not all inclusive. Always check with your local insurance carriers as policies vary by region.

The final decision for the coding of a procedure must be made by the physician considering regulations of insurance carriers and any local, state or federal laws that apply to the physician’s practice. The SNMMI and its representatives disclaim any liability arising from the use of these opinions.

An Exclusive Offer Just for You:

Maximize your earnings in the remaining 6 months of 2024 by seizing our 2024 close-out opportunity and securing your financial future with any one of our radiology resources. Order your resource today and enjoy 50% savings while enhancing your coding and billing expertise. This exclusive offer is valid until July 5th, and inventory is limited.

To receive your 50% discount, use the code CO5024 at checkout on our web store.Act now before this exclusive offer expires on July 5th!

Facebook
Twitter
LinkedIn

Bryan Nordley

Bryan Nordley is a seasoned professional writer, strategist, and researcher with over a decade’s worth of combined experience. Bryan launched his professional health writing career at the University of British Columbia’s Faculty of Medicine, one of the top 30 faculty of medicine programs in the world, working under the School of Public Health as a communications assistant. From there, he expanded his expertise and knowledge into private healthcare and podiatry before taking the role of healthcare writer at MedLearn Media. Bryan is the lead writer for the MedLearn Publishing brand previously producing both the acclaimed radiology and laboratory compliance manager newsletter products, while currently writing the compliance questions of the week which reach over 10,000 subscribers, creating the MedLearn Publishing Insights blogs and collaborating with operations and nationally renowned subject matter experts, in addition to serving as an editor for a variety of MedLearn publications along with marketing initiatives. Bryan continues to keep his pulse on the latest healthcare industry news, analyzing and reporting with strategic insight.

Related Stories

Abe Sutton and MA Reform

Abe Sutton and MA Reform

From think tanks to federal agencies, health policy in the U.S. is often shaped by voices we don’t always see in the headlines. Abe Sutton,

Read More

Leave a Reply

Please log in to your account to comment on this article.

Featured Webcasts

2026 IPPS Masterclass 3: Master MS-DRG Shifts and NTAPs

2026 IPPS Masterclass Day 3: MS-DRG Shifts and NTAPs

This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 14, 2025
2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

2026 IPPS Masterclass Day 2: Master ICD-10-PCS Changes

This second session in our 2026 IPPS Masterclass will feature a review the FY26 changes to ICD-10-PCS codes. This information will be presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 13, 2025
2026 IPPS Masterclass 1: Master ICD-10-CM Changes

2026 IPPS Masterclass Day 1: Master ICD-10-CM Changes

This first session in our 2026 IPPS Masterclass will feature an in-depth explanation of FY26 changes to ICD-10-CM codes and guidelines, CCs/MCCs, and revisions to the MCE, presented by presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.

August 12, 2025

Trending News

Featured Webcasts

The Two-Midnight Rule: New Challenges, Proven Strategies

The Two-Midnight Rule: New Challenges, Proven Strategies

RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.

June 19, 2025
Open Door Forum Webcast Series

Open Door Forum Webcast Series

Bring your questions and join the conversation during this open forum series, live every Wednesday at 10 a.m. EST from June 11–July 30. Hosted by Chuck Buck, these fast-paced 30-minute sessions connect you directly with top healthcare experts tackling today’s most urgent compliance and policy issues.

June 11, 2025
Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Open Door Forum: The Changing Face of Addiction: Coding, Compliance & Care

Substance abuse is everywhere. It’s a complicated diagnosis with wide-ranging implications well beyond acute care. The face of addiction continues to change so it’s important to remember not just the addict but the spectrum of extended victims and the other social determinants and legal ramifications. Join John K. Hall, MD, JD, MBA, FCLM, FRCPC, for a critical Q&A on navigating substance abuse in 2025.  Register today and be a part of the conversation!

July 16, 2025

Trending News

CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24